DDInter901 DDInter832
Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Ibutilide {u} (Compound) resembles {v} (Compound) Dronedarone
Ibutilide {u} (Compound) binds {v} (Gene) KCNH7
Ibutilide {u} (Compound) causes {v} (Side Effect) Bradycardia
Ibutilide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Ibutilide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Thalidomide
Ibutilide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lidocaine
Ibutilide {u} may lead to a major life threatening interaction when taken with {v} Mefloquine
Ibutilide {u} may lead to a major life threatening interaction when taken with {v} Anagrelide
Ibutilide (Compound) resembles Dronedarone (Compound)
Ibutilide (Compound) binds KCNH7 (Gene)
Ibutilide (Compound) causes Bradycardia (Side Effect)
Ibutilide may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Ibutilide may cause a moderate interaction that could exacerbate diseases when taken with Thalidomide
Ibutilide may cause a moderate interaction that could exacerbate diseases when taken with Lidocaine
Ibutilide may lead to a major life threatening interaction when taken with Mefloquine
Ibutilide may lead to a major life threatening interaction when taken with Anagrelide